Hansa Biopharma

Hansa Biopharma is a commercial-stage biopharmaceutical company focused on developing innovative immunomodulating therapies for people living with rare immunological conditions. Founded in 2007 and headquartered in Lund, Sweden, Hansa has a growing presence in Europe and the US. The company is listed on the Nasdaq Stockholm and its vision is a world where all patients with rare immunologic diseases can lead long and healthy lives. Hansa's unique technology platform utilizes antibody-cleaving enzymes to target and inactivate pathogenic IgG antibodies, which can be harmful in autoimmune diseases and interfere with life-saving gene therapies or transplantation procedures.

Hansa is committed to advancing science in areas of high unmet need and ensuring equitable access to new medicines. They foster a culture that values authentic and transparent communication, and they actively promote diversity and inclusion within their workforce. Hansa has been recognized as a Great Place to Work for four consecutive years, showcasing their dedication to creating a positive and supportive environment for their employees.

Hansa Biopharma is a global company with offices in both Europe and the US. They pride themselves on being a diverse and inclusive workplace, which includes offering a flexible work environment. The company has been awarded the Great Place to Work designation for four years in a row, indicating a positive employee experience and leadership behavior. While the company website does not explicitly detail specific work flexibility options, the emphasis on a positive work environment and a diverse workforce suggests that some level of work flexibility is likely available.

Hansa Biopharma prioritizes employee well-being, offering benefits designed to support their physical and mental health. Beyond competitive compensation, they provide a comprehensive package including healthcare, pension, and leave programs, as well as opportunities for professional development. Additionally, Hansa fosters a collaborative and inclusive workplace culture, encouraging innovation and recognizing employee achievements.

Hansa Biopharma is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative immunomodulating therapies to treat rare immunologic diseases. Their mission is to leverage their unique antibody-cleaving enzyme technology platform to develop lifesaving and life-altering treatments, ensuring equitable access to these medicines and generating value for society as a whole.

Hansa Biopharma fosters a collaborative and inclusive culture that values transparency and diversity. The company promotes a strong sense of purpose, encouraging its employees to be innovative and push boundaries. This is reflected in their commitment to ethical and responsible business practices, as well as their efforts to create an environment where all employees feel empowered and valued. Hansa has been recognized for its exceptional workplace culture, earning the Great Place to Work designation for four consecutive years.

Hansa Biopharma is committed to building an inclusive and diverse workplace where all employees feel valued and empowered. Their diversity and inclusion policy outlines a required blend of geographical and cultural backgrounds, professional experiences, and knowledge, including gender balance, in their board and leadership. They conduct yearly salary surveys to ensure equal pay for equivalent work between men and women, demonstrating their commitment to fostering a culture that embraces difference and celebrates individual talent.